Amyloid Beta-directed Antibody [EPC] - N0000193951

Pharmacologic Code	N0000193951
Pharmacologic Name	Amyloid Beta-directed Antibody
Pharmacologic Uses	amyloid beta-directed antibody
Pharmacologic Concept	Established Pharmacologic Classes - [EPC]
Pharmacologic Concept Description	An established pharmacologic class is a term or phrase that is scientifically valid and clinically meaningful according to the following definitions: A scientifically valid pharmacologic class is supported by documented and submitted empiric evidence showing that the drug's pharmacologic class is known, not theoretical, and relevant and specific to the indication. A clinically meaningful pharmacologic class term or phrase enhances the ability of professionals to understand physiologic effects related to the indication or to anticipate undesirable effects that may be associated with the drug or pharmacologic class.

The table contains 3 products whose active ingredient are classified under the same pharmacologic class Amyloid Beta-directed Antibody [EPC].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	62856-212	Leqembi	Non-Proprietary Name: Lecanemab	Injection, Solution	Intravenous	Eisai Inc.	ACTIVE
	62856-215	Leqembi	Non-Proprietary Name: Lecanemab	Injection, Solution	Intravenous	Eisai Inc.	ACTIVE
	62856-220	Lecanemab Autoinjector	Non-Proprietary Name: Lecanemab-irmb	Injection, Solution	Subcutaneous	Eisai Inc.	ACTIVE